Unibest

Pharmaceutical intermediates

Saxagliptin Intermediates

5 pharmaceutical intermediates for Saxagliptin. Indication: Type 2 diabetes mellitus.

提交项目All intermediates

About Saxagliptin

Originator
Bristol Myers Squibb
Indication
Type 2 diabetes mellitus
Approved Date
07/31/2009
DS/DP
11/30/2028

Available intermediates

5 intermediates currently listed for Saxagliptin. Request specifications, documentation or a quotation for any item below.

Saxagliptin intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
(1S,3S,5S)-2-Azabicyclo[3.1.0]hexane-3-carboxamide methanesulfonate709031-45-8//
Boc-3-Hydroxy-1-adamantyl-D-glycine361442-00-4//
(1S,3S,5S)-3-(Aminocarbonyl)-2-azabicyclo[3.1.0]hexane-2-carboxylic acid tert-butyl ester361440-67-7//
(S)-1-Boc-2,3-dihydro-2-pyrrolecarboxylic acid ethyl ester178172-26-4//
(1R,3R,5R)-2-(tert-Butoxycarbonyl)-2-azabicyclo[3.1.0]hexane-3-carboxylic acid1148048-39-8//

Other programs under S

SaracatinibSarecycline HydrochlorideSarolanerSeladelparSeltorexantSemaglutideSitafloxacin hydrate Sofosbuvir

Building toward Saxagliptin?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →